Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

Association between the Hepatic Lipase Promoter Region Polymorphism (-514 C/T) and the Presence and Severity of Premature Coronary Artery Disease.

Goodarzynejad H, Boroumand M, Behmanesh M, Ziaee S, Jalali A, Pourgholi L.

J Tehran Heart Cent. 2017 Jul;12(3):119-127.

2.

[ESTIMATING THE EFFECTIVENESS OF HYPOLIPIDEMIC THERAPY WITH ROSUVASTATIN IN PATIENTS WITH CORONARY HEART DISEASE DEPENDING ON THE GENOTYPE OF LIPOPROTEIN LIPASE].

Zvyagina MV, Mal GS, Bushueva OY, Alymenko MA, Bykanova MA, Letova IM, Gribovskaya IA, Churnosov MI, Solodilova MA, Polonikov AV.

Eksp Klin Farmakol. 2016;79(1):15-9. Russian.

PMID:
27159952
3.

Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner.

Guardiola M, Echeverria P, González M, Vallvé JC, Puig J, Clotet B, Ribalta J, Negredo E.

AIDS Res Hum Retroviruses. 2015 Sep;31(9):882-8. doi: 10.1089/AID.2015.0061. Epub 2015 Jul 20.

PMID:
26101956
4.

The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype.

Brunzell JD, Zambon A, Deeb SS.

Biochim Biophys Acta. 2012 Mar;1821(3):365-72. doi: 10.1016/j.bbalip.2011.09.008. Epub 2011 Sep 25. Review.

5.

Hepatic lipase gene -514C>T variant is associated with exercise training-induced changes in VLDL and HDL by lipoprotein lipase.

Brinkley TE, Halverstadt A, Phares DA, Ferrell RE, Prigeon RL, Hagberg JM, Goldberg AP.

J Appl Physiol (1985). 2011 Dec;111(6):1871-6. doi: 10.1152/japplphysiol.00567.2011. Epub 2011 Sep 29.

6.

Liver fat in the pathogenesis of insulin resistance and type 2 diabetes.

Yki-Järvinen H.

Dig Dis. 2010;28(1):203-9. doi: 10.1159/000282087. Epub 2010 May 7. Review.

PMID:
20460912
8.

Small and dense LDL in familial combined hyperlipidemia and N291S polymorphism of the lipoprotein lipase gene.

López-Ruiz A, Jarabo MM, Martínez-Triguero ML, Morales-Suárez-Varela M, Solá E, Bañuls C, Casado M, Hernández-Mijares A.

Lipids Health Dis. 2009 Mar 31;8:12. doi: 10.1186/1476-511X-8-12.

9.

trans-Free margarines prepared with canola oil/palm stearin/palm kernel oil-based structured lipids.

Kim BH, Lumor SE, Akoh CC.

J Agric Food Chem. 2008 Sep 10;56(17):8195-205. doi: 10.1021/jf801412v. Epub 2008 Aug 16.

PMID:
18707123
10.

Interactions between hepatic lipase and apolipoprotein E gene polymorphisms affect serum lipid profiles of healthy Canadian adults.

Wood KC, Fullerton MD, El-Sohemy A, Bakovic M.

Appl Physiol Nutr Metab. 2008 Aug;33(4):761-8. doi: 10.1139/H08-054.

PMID:
18641720
11.

The -250G>A promoter variant in hepatic lipase associates with elevated fasting serum high-density lipoprotein cholesterol modulated by interaction with physical activity in a study of 16,156 Danish subjects.

Grarup N, Andreasen CH, Andersen MK, Albrechtsen A, Sandbaek A, Lauritzen T, Borch-Johnsen K, Jørgensen T, Schmitz O, Hansen T, Pedersen O.

J Clin Endocrinol Metab. 2008 Jun;93(6):2294-9. doi: 10.1210/jc.2007-2815. Epub 2008 Mar 25.

PMID:
18364377
12.

[Gene-diet interactions in atherogenic dyslipidemias (part 2)].

Zák A, Slabý A.

Cas Lek Cesk. 2007;146(12):902-8. Review. Czech.

PMID:
18257402
13.

High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants.

van Acker BA, Botma GJ, Zwinderman AH, Kuivenhoven JA, Dallinga-Thie GM, Sijbrands EJ, Boer JM, Seidell JC, Jukema JW, Kastelein JJ, Jansen H, Verhoeven AJ; REGRESS Study Group.

Atherosclerosis. 2008 Sep;200(1):161-7. doi: 10.1016/j.atherosclerosis.2007.11.019. Epub 2007 Dec 27.

PMID:
18164013
14.

Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.

Perron P, Brisson D, Santuré M, Blackburn P, Bergeron J, Vohl MC, Després JP, Gaudet D.

J Endocrinol Invest. 2007 Jul-Aug;30(7):551-7.

PMID:
17848837
15.

Association of lipase lipoprotein polymorphisms with myocardial infarction and lipid levels.

Gigek Cde O, Chen ES, Cendoroglo MS, Ramos LR, Araujo LM, Payão SL, Smith Mde A.

Clin Chem Lab Med. 2007;45(5):599-604.

PMID:
17484619
16.

The lipoprotein lipase gene in combined hyperlipidemia: evidence of a protective allele depletion.

Wung SF, Kulkarni MV, Pullinger CR, Malloy MJ, Kane JP, Aouizerat BE.

Lipids Health Dis. 2006 Jul 5;5:19.

17.

Relationship between plasma HDL subclasses distribution and lipoprotein lipase gene HindIII polymorphism in hyperlipidemia.

Long S, Tian Y, Zhang R, Yang L, Xu Y, Jia L, Fu M.

Clin Chim Acta. 2006 Apr;366(1-2):316-21. Epub 2005 Dec 20.

PMID:
16364275
18.

Lipoprotein subclass and particle size differences in Afro-Caribbeans, African Americans, and white Americans: associations with hepatic lipase gene variation.

Miljkovic-Gacic I, Bunker CH, Ferrell RE, Kammerer CM, Evans RW, Patrick AL, Kuller LH.

Metabolism. 2006 Jan;55(1):96-102.

PMID:
16324926
19.
20.

The lipoprotein lipase S447X polymorphism and plasma lipids: interactions with APOE polymorphisms, smoking, and alcohol consumption.

Lee J, Tan CS, Chia KS, Tan CE, Chew SK, Ordovas JM, Tai ES.

J Lipid Res. 2004 Jun;45(6):1132-9. Epub 2004 Apr 1.

Supplemental Content

Loading ...
Support Center